INTRODUCTION
The aging process causes a decrease in subcutaneous fat and dermal collagen, resulting in grooves and facial depressions that are accentuated over time owing to volumetric loss and muscle action. Treatment of facial aging, previously focused only on the traction of the tissues, is currently based on restoration of volume and facial contours.
The ideal filler must be autologous, long-lasting, or permanent without immunological or toxic effects and should act to slow down or prevent the aging process. Permanent fillers such as paraffin, liquid silicone, Teflon, and polymethylmethacrylate (PMMA) have a rough surface that cannot be phagocytosed, eventually forming granulomas.
Particles smaller than 15 µm are generally phagocytized and can be transported to lymph nodes. From a clinical perspective, all injectable fluids cause foreign-body reaction to varying degrees. Until the mechanism of granuloma formation is fully understood, it will not be possible to predict its development 1,2 .
CASE REPORT
A 53-year-old white woman who had no comorbidities or smoking habit underwent PMMA filling in the nasolabial folds, which was performed by a colleague, 7 years before a facelift. On June 7, 2011, she underwent a facelift and chin silicone prosthesis implant without intercurrences and developed a hematoma in the left hemiface in the immediate postoperative period, which was immediately drained. On the 30 th postoperative day, 2 ml of seroma was aspirated from the left submandibular region, with new drainage being performed 20 days after the first.
On September 12 and 19, infiltration with dipropionate and betamethasone phosphate was performed; but on September 25, an organized tumorous formation was observed in the left submandibular region. Ultrasonography was performed in this region and indicated evidence of a solid, heterogeneous nodular formation, with interposed echogenic foci and Doppler flow, measuring 2.6 x 1.3 cm, besides two well-defined hypoechoic formations, measuring 1.3 x 0.7 and 1.5 x 0.7 cm, respectively, adjacent to the main lesion. No alterations in the submandibular glands nor lymphadenopathy were observed.
On October 5, nuclear magnetic resonance imaging was performed and revealed lymphadenopathy in the left submandibular region, bilateral volumetric increase of the tonsils, lymphadenomegaly to the right, and ovoid subcutaneous images with low signal intensities on T1 and T2 in the submandibular area due to the cutaneous filling material. Twenty-five days after resection of the lesion, the patient evolved with a new inflammatory process, this time in the right submandibular region. Thus, administration of 500 mg of ciprofloxacin every 12 hours was initiated, which resulted in a significant improvement of the lesions. New infiltration with betamethasone was performed on January 30, 2012. On May 9, 2012, the lesions were excised, thereby achieving resolution of the case. 
DISCUSSION
Facial aging is characterized basically by flaccidity of tissues, formation of wrinkles, and volumetric reduction of the face with variable intensity. This flaccidity can be corrected by several surgical techniques, but these techniques are all inadequate for correcting the loss of subcutaneous volume and leave marks on the skin via the muscular action during aging.
A more ideal solution would be fat grafting, but the lack of uniformity of results, difficulty of graft vascularization, fat absorption, and the need for surgical harvesting procedures have led to the search for an appropriate fat replacement 3 .
In approaching a patient who desires esthetic improvement of these areas, the physician should be able to assess the quality and position of the subcutaneous tissues. With an assessment of facial esthetics and a practical knowledge of the capabilities and limitations of each filler, the plastic surgeon will be able to use the most appropriate filler to achieve better esthetic results with the lowest risk to the patient 4 .
The most recent use of PMMA dates back to when a concern emerged in the past regarding the use of liquid silicone 5 . PMMA, due to its low cost and unrestricted control of sales, is being used indiscriminately by nonmedical professionals and physicians without appropriate expertise. In addition, granulomatous complications may occur regardless of the technique used 6 .
PMMA is non-allergenic but depends on the vehicle used to be considered completely inert in the body. Complications can appear in the form of granuloma, when its application is superficial. The use of microcannulas prevents ecchymosis and intravascular injections 3 .
Regarding histological changes, PMMA implantation in the body induces the production of macrophages, which indicates microspheres of incompatible sizes for phagocytosis and the process evolves to granuloma formation 3, 6 . According to the literature, granuloma formation occurs as a complication at a rate of 0.01% to 2.5% of all PMMA applications, considering the use of PMMA fillers from different manufacturers. The presence of small nodules and painless masses is common after the application of PMMA but is almost never a formal complaint of patients.
Lemperle et al. 7 described three mechanisms by which PMMA microspheres can migrate, as follows: the hematogenic route by inadvertent intravascular injection; the lymphatic route by accidental injection of thick lymphatic vessels, with the local lymph nodes and lungs as the more probable final destinations; and phagocytosis of microspheres by macrophages in the implantation site, which then migrate to local lymph nodes.
Neves et al. 8 performed an experimental study in rats after intradermal infiltration of PMMA and in the glabella. After 30 days, the animals were killed and samples of the lungs, liver, spleen, and kidneys were submitted for histopathological study. No PMMA microspheres were found in the tissues analyzed.
The reported case refers to that of a 53-year-old patient who was previously subjected to PMMA filling in the nasolabial folds and submitted to a facelift and chin prosthesis implant after 7 years, evolving with foreign-body granuloma in a location distant from the site of PMMA application. As no lymph node was found in the anatomopathological study of the lesions, despite being observed on the nuclear magnetic resonance imaging requested, the migration path of the alloplastic materials in this case is, therefore, obscure.
CONCLUSION
Permanent fillers should be used with caution. Clinical treatment is the first option for complications and the surgical treatment of selected cases in which the clinical treatment was not successful 6 , as in our case. The treatment is long and complex, requiring caution on the part of the surgeon and perseverance of the patient.
COLLABORATIONS RNS Analysis and/or data interpretation; statistical
analysis; conception and design of the study; completion of operations and/or experiments; and writing of the manuscript or critical review of its contents SGM Analysis and/or data interpretation; statistical analysis; conception and design of the study; completion of operations and/or experiments; and writing of the manuscript or critical review of its contents ECA Analysis and/or data interpretation; statistical analysis; and writing of the manuscript or critical review of its contents ALAF Analysis and/or data interpretation; statistical analysis; and writing of the manuscript or critical review of its contents ÊGA Analysis and/or data interpretation; statistical analysis; and writing of the manuscript or critical review of its contents LASL Final approval of the manuscript
